The HFpEF Obesity Phenotype: The Elephant in the Room

Journal of the American College of Cardiology

Volumn 68, Issue 2, 2016, Pages 200-203

  Kitzman, Dalane W ^a   Shah, Sanjiv J ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

adipose; exercise intolerance; heart failure with preserved ejection fraction; New York Heart Association

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

BODY COMPOSITION; BODY MASS; CELL FUNCTION; DISEASE ASSOCIATION; EDITORIAL; FOLLOW UP; GENETIC ASSOCIATION; HEART DEATH; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; KIDNEY FAILURE; MITOCHONDRION; NEW YORK HEART ASSOCIATION CLASS; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION; EXERCISE TOLERANCE; HEART FAILURE; HEART STROKE VOLUME;

EXERCISE TOLERANCE; HEART FAILURE; HUMANS; OBESITY; PHENOTYPE; STROKE VOLUME;

EID: 84990221063     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.05.019     Document Type: Editorial

References (24)

1. 1 Dalos, D., Mascherbauer, J., Zotter-Tufaro, C., et al. Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction. J Am Coll Cardiol 68 (2016), 189–199.
2. 2 Haykowsky, M., Kouba, E.J., Brubaker, P.H., et al. Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Cardiol 113 (2014), 1211–1216.
3. 3 Beavers, K., Beavers, D., Houston, D., et al. Associations between body composition and gait-speed decline: results from the Health, Aging, and Body Composition study. Am J Clin Nutr 97 (2013), 552–560.
4. 4 Normandin, E., Houston, D.K., Nicklas, B.J., Caloric restriction for treatment of geriatric obesity: do the benefits outweigh the risks?. Curr Opin Cardiol 4 (2015), 143–155.
5. 5 Katzel, L.I., Bleecker, E.R., Colman, E.G., et al. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial. JAMA 274 (1995), 1915–1921.
6. 6 Paulus, W., Tschope, C., A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62 (2013), 263–271.
7. 7 Sharma, K., Kass, D., Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res 115 (2014), 79–96.
8. 8 Parisi, V., Rengo, G., Perrone-Filardi, P., et al. Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure. Circ Res 118 (2016), 1244–1253.
9. 9 VanWagner, L.B., Wilcox, J.E., Colangelo, L.A., et al. Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: a population-based study. Hepatology 62 (2015), 773–783.
10. 10 Haykowsky, M., Brubaker, P., Morgan, T., et al. Impaired aerobic capacity and physical functional performance in older heart failure patients with preserved ejection fraction: role of lean body mass. J Gerontol A Biol Sci Med Sci 68 (2013), 968–975.
11. 11 Morkedal, B., Vatten, L., Romundstad, P., et al. Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals. The HUNT Study, Norway. J Am Coll Cardiol 63 (2014), 1071–1078.
12. 12 Kenchaiah, S., Evans, J.C., Levy, D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002), 305–313.
13. 13 Redfield, M., Chen, H., Borlaug, B., et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309 (2013), 1268–1277.
14. 14 Haass, M., Kitzman, D.W., Anand, I.S., et al. Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction / clinical perspective. Circ Heart Fail 4:3 (2011), 324–331.
15. 15 Anjan, V.Y., Loftus, T.M., Burke, M.A., et al. Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction. Am J Cardiol 110 (2012), 870–876.
16. 16 Shah, S.J., Heitner, J.F., Sweitzer, N.K., et al. Baseline characteristics of patients in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist trial. Circ Heart Fail 6 (2013), 184–192.
17. 17 Massie, B.M., Carson, P.E., McMurray, J.J., et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359 (2008), 2456–2467.
18. 18 Ndumele, C.E., Matsushita, K., Sang, Y., et al. NT-proBNP and heart failure risk among individuals with and without obesity: the ARIC study. Circulation 133 (2016), 631–638.
19. 19 Bertoni, A.G., Wagenknecht, L.E., Kitzman, D.W., et al. Impact of the Look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes. Obesity Res 20 (2012), 1511–1518.
20. 20 Rejeski, W., Marsh, A., Chmelo, E., Rejeski, J., Obesity, intentional weight loss and physical disability in older adults. Obes Rev 11 (2010), 671–685.
21. 21 Sjostrom, L., Peltonen, M., Jacobson, P., et al. Bariatric surgery and long-term cardiovascular events. JAMA 307 (2012), 56–65.
22. 22 Miranda, W., Batsis, J., Sarr, M., et al. Impact of bariatric surgery on quality of life, functional capacity, and symptoms in patients with heart failure. Obes Surg 23 (2013), 1011–1015.
23. 23 Kitzman, D.W., Brubaker, P., Morgan, T., et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomised clinical trial. JAMA 315 (2016), 36–46.
24. 24 Kritchevsky, S.B., Beavers, K.M., Miller, M.E., et al. Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials. PLoS ONE, 10, 2015, e0121993.